alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › sh-sy5y

sh-sy5y

2 studies tagged sh-sy5y, dated 2005-09-06 to 2014-12-20. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. Systems genomics evaluation of the SH-SY5Y neuroblastoma cell line as a model for Parkinson's disease 2014-12-20
  2. Unequal neuroprotection afforded by the acetylcholinesterase inhibitors galantamine, donepezil, and rivastigmine in SH-SY5Y neuroblastoma cells: role of nicotinic receptors 2005-09-06

Studies

2 studies carry this tag.

Date range

2005 to 2014

Top journals

  • BMC genomics 1
  • The Journal of pharmacology and experimental therapeutics 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Systems genomics evaluation of the SH-SY5Y neuroblastoma cell line as a model for Parkinson's disease

    ✓ Peer-reviewed alzhub usefulness score 40 out of 100. BMC genomics 2014-12-20 Genetics

    The systems genomics approach showed consistency across different biological levels (DNA, RNA and protein concentrations).

  2. Unequal neuroprotection afforded by the acetylcholinesterase inhibitors galantamine, donepezil, and rivastigmine in SH-SY5Y neuroblastoma cells: role of nicotinic receptors

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. The Journal of pharmacology and experimental therapeutics 2005-09-06 Treatments

    Donepezil, rivastigmine, and galantamine are three drugs with acetylcholinesterase (AChE)-inhibiting activity that are currently being used to treat patients suffering from Alzheimer's disease.

All topic tags with their study counts